Meaningful Results


HGE Health is helping Providers and Payors drive results across their patient populations, while establishing standards of care for COPD management and clinical outcomes


Patient Engagement

More than 80% of patients consistently submit their COPD symptoms on a daily basis, seven days a week using HGE Health


Physician Engagement

Average Provider response time to Patients' symptom changes improved from 4+ days down to 6 hrs using HGE Health


lower utilization

HGE Health's Partners experience a considerable reduction of COPD patient-related Emergency Room visits, Inpatient admissions,  Inpatient days, and readmissions

Proven Outcomes

HGE Health ensures that Patient engagement links to outcomes


Sustained Engagement

Daily compliance consistently exceeded 80% across patient populations


Reduced Utilization

Annualized utilization outcomes by type of service both before and after enrollment in HGE Health


Utilization Avoidance

Achieved lower utilization than expected based on event rates, even for patients with no recent prior admissions


5 : 1 ROI

Engagement + Outcomes Results in Tangible ROI for HGE Health's Partners.  Typically, Providers and Payors begin to experience patient-level ROI within the first 120 days of launch


HGE Health Research

HGE Health continues to push forward to better understand and elevate the quality of care for people living with COPD


Published Articles

  1. Markers of Dental Health Correlate with Daily Respiratory Symptoms in COPD (Published Online, Journal of the COPD Foundation, Accepted November 8, 2017, Published as Original Research Volume 5 | Issue 2 | 2018)

  2. Use of a SmartPhone/Tablet-Based Bidirectional Telemedicine Disease Management Program Facilitates Early Detection and Treatment of COPD Exacerbation Symptoms (Published Online, Telemedicine and e-Health, Printed Online October 2015)
  3. A Telemedicine-Based Intervention Reduces the Frequency and Severity of COPD Exacerbation Symptoms: A Randomized Controlled Trial (Published Online, Telemedicine and e-Health, Printed Publication coming February 2016)
  4. Outcomes of COPD Exacerbations Treated with Corticosteroids, Antibiotics, or Both (Published Online, International Scholarly Research Network, Accepted July, 2011)
  5. The Effect of Chronic Sputum Production on Respiratory Symptoms in Severe COPD (Published Online, COPD: Journal of Chronic Obstructive Pulmonary Disease, Accepted August, 2011)
  6. Daily Peak Flow Expiratory Flow Rate and Disease Instability in Chronic Obstructive Pulmonary Disease (Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation, Published November 2015)


HGE Health Related Clinical Trials (


Evaluation of COPD Co-Pilot – BTG/PneumRx, Inc.  [ACTIVE, NOT RECRUITING]


COPD Co-Pilot AIR Substudy of CLN0014 – BTG/PneumRx, Inc. [ENROLLING BY INVITATION]


Evaluation of COPD Co-Pilot – BTG/PneumRx, Inc. [COMPLETED]


Ability of an oral urease test to assess the oral microbiome in current and former smokers with COPD – AVISA Pharma, Inc.  [COMPLETED]


A Phase 2a Study to Assess Safety, Daily Symptoms, Pharmacokinetics (PK), and Biomarkers of YPL-001 in Chronic Obstructive Pulmonary Disease (COPD) Patients – Yungjin Pharma, Co.  [COMPLETED]


Respiration of Rate Monitoring in COPD Patients - ResMed  [COMPLETED]


MAY 2018 American thoracic Society (ATS) Meeting

HGE Health Abstracts:

  1. No. 11424,   Effects of BMI on COPD Exacerbation and Daily Symptoms,   B21 - EXACERBATIONS AND READMISSION ISSUES IN COPD,   Jennifer So, MD,   Monday, May 21, 2018   9:15AM-11:15AM
  2. No. 14439,   Effect of Positive Airway Pressure (PAP) on the Daily Burden of COPD Respiratory Symptoms in Patients with COPD and OSA,   B40 - CLINICAL ISSUES IN COPD I,   Rachel Criner, MD,  Monday, May 21   9:15AM-4:15PM
  3. No. 11053,   Daily Measurements of Nocturnal Respiratory Rate Variability May Predict COPD Exacerbations,   C24 - NEW TECHNOLOGIES FOR MANAGING COPD,   Jennifer So, MD,   Tuesday, May 22, 2018   9:15AM-11:15 AM

  4. No. 14396,   Flossing and Regular Dental Visits in Patients with COPD Is Associated with Fewer Days with Worse Respiratory Symptoms,   C44 - CLINICAL ISSUES IN COPD II,   Brooke Heyman, MD,   Tuesday, May, 22 9:15AM-4:15PM

  5. No. 10331,   Combining Non-Contact Nocturnal Respiratory Monitoring with Respiratory Symptom Characterization to Enhance Early Detection of COPD Exacerbation,   C24 - NEW TECHNOLOGIES FOR MANAGING COPD,   Sean Duffy, MD,   Tuesday,   May 22   9:15AM-11:15AM

  6. No. 14552,   Impact of Predictive Analytics to Identify Risk of Readmissions in COPD Patients for Better Management Post Discharge,   C42 -  CONTEMPORARY TOPICS IN COPD,   Gerard Criner, MD,   Tuesday,   May 22,   9:15AM-4:15PM

  7. No. 7975,   Impact of Mepolizumab on Daily Symptoms and Rate of Treated Exacerbations in Eosinophilic COPD,   D101 -MECHANISTIC AND TRANSLATIONAL STUDIES IN COPD,   Gustavo Fernandez Romero, MD,   Wednesday,   May 23   1:30PM-3:30PM


Published American thoracic Society (ATS) Abstracts

(Sample of Select ATS Abstracts)

  1. Exacerbation Rates and Recovery Outcomes Following Glucocorticoid Treatment in Outpatients with Chronic Obstructive Pulmonary Disease
  2. Impact of Device Type and Patient Demographics on Compliance with a Telemedicine-Based Disease Management Program in COPD
  3. Impact of Nebulized Long-Acting Beta Agonists on Daily Symptoms of COPD Patients
  4. Greater Number of Teeth in COPD Patients with Poor Dental Health Correlates with Worse Daily Respiratory Symptoms
  5. Daily Respiratory Symptoms Based on Degree of Airflow Obstruction in Patients with COPD
  6. The Use of Oral Urease Activity as an Assessment of COPD Symptoms in Current and Former Smokers
  7. Patients with a COPD Emphysematous Phenotype Have Worse Daily Respiratory Symptoms
  8. Response Patterns of Respiratory Symptoms to Administration of Antibiotic Therapy in Outpatient Chronic Obstructive Pulmonary Disease Patients
  9. The Effect of AECOPD on Daily Peak Expiratory Flow
  10. Use of the Temple COPD phone Telemedicine Program in the Early Detection And Treatment of Acute COPD Exacerbations
  11. Evaluation of the COPD phone Telemedicine System in Daily COPD Symptom Reporting: PA-SCOPE
  12. Relationship of a COPD Daily Symptom Score to Quality of Life (QOL) and Functional Status
  13. Efficacy of Corticosteroids and Antibiotics in AECOPD
  14. Effect of a Telemedicine-Based Treatment Program for Acute COPD Exacerbation on Quality of Life: PA-SCOPE
  15. Use of Symptoms To Predict Treatment Failure in Acute Exacerbations of COPD
  16. COPD Patients Reveal Seasonal Trends in Daily Symptoms Using Electronic Reporting Tool
  17. Prevalence of Daily Respiratory Symptoms Reported by Electronic Diary Monitoring in COPD Patients: PA-SCOPE
  18. Evaluation of an Electronic Diary for Daily COPD Symptom Reporting: PA-SCOPE
  19. Participation in a Telemedicine Program for Chronic Obstructive Pulmonary Diseases Improves Daily Symptoms
  20. A Telemedicine-Based Disease Management Program for Daily COPD Symptom Reporting Reduces Hospitalizations, Hospital Length of Stay, and Emergency Room Visits
  21. Response of Respiratory Symptoms in Outpatient Chronic Obstructive Pulmonary Disease Patients to Administration of Prednisone Therapy
  22. Daily Peak Expiratory Flow Rate Measured at Home Reflects Laboratory Measurement of Peak Expiratory Flow Rate in Chronic Obstructive Pulmonary Disease (COPD)
  23. Effects of Age, Gender, Race, and Degree of Baseline Airflow Obstruction on Daily Peak Expiratory Flow Rate (PEFR) Variability in Moderate to Severe COPD

Want a partner to improve COPD care?

Join Us